CIBC Asset Management
HZNP

CIBC Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CIBC Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,020
Closed -$928K – 1159
2023
Q3 		$928K Buy
8,020
+118
+1% +$12.7K ﹤0.01% 654
2023
Q2 		$813K Buy
7,902
+5
+0.1% +$528 ﹤0.01% 678
2023
Q1 		$862K Buy
7,897
+318
+4% +$35.1K ﹤0.01% 673
2022
Q4 		$862K Sell
7,579
-2,763
-27% -$229K ﹤0.01% 684
2022
Q3 		$640K Sell
10,342
-436
-4% -$30.5K ﹤0.01% 722
2022
Q2 		$860K Sell
10,778
-19,025
-64% -$1.8M ﹤0.01% 681
2022
Q1 		$3.14M Buy
29,803
+19,376
+186% +$1.89M 0.01% 453
2021
Q4 		$1.12M Buy
10,427
+1,209
+13% +$132K ﹤0.01% 669
2021
Q3 		$1.01M Sell
9,218
-29,154
-76% -$3.03M ﹤0.01% 676
2021
Q2 		$3.59M Buy
38,372
+4,046
+12% +$372K 0.01% 411
2021
Q1 		$3.16M Buy
34,326
+27,362
+393% +$2.31M 0.01% 410
2020
Q4 		$509K Hold
6,964
– – ﹤0.01% 745
2020
Q3 		$541K Buy
6,964
+172
+3% +$11.8K ﹤0.01% 696
2020
Q2 		$377K Hold
6,792
– – ﹤0.01% 746
2020
Q1 		$201K Hold
6,792
– – ﹤0.01% 878
2019
Q4 		$246K Buy
+6,792
New +$208K ﹤0.01% 964

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CIBC Asset Management's HZNP Position: Q4 2023 in Review

CIBC Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 8,020 shares — an estimated $928K sold.

CIBC Asset Management first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $3.59M in Q2 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CIBC Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CIBC Asset Management sold 8,020 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $928K.
  • CIBC Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
  • CIBC Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.59M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CIBC Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.